

(€ millions) | 2007 | % of sales | 2006 | % of sales | 07/ 06 |
Southern Europe(1) | 33,32 | 78,3 | 27,57 | 77,5 | 21 |
Other EU countries | 8,07 | 19,0 | 6,80 | 19,1 | 19 |
Other markets | 1,17 | 2,7 | 1,22 | 3,4 | (4) |
SLIT | 34,63 | 81,4 | 27,66 | 77,7 | 25 |
SCIT | 6,17 | 14,5 | 6,27 | 17,6 | (2) |
Other products | 1,75 | 4,1 | 1,66 | 4,7 | 5 |
Total Q1 sales | 42,55 | 100,0 | 35,59 | 100,0 | 20 |
(1) Portugal, Spain, France, Italy, Greece
2007 first quarter sales had further significant growth of over 20% on all European markets. Other markets were temporarily impacted by delays in deliveries.
The strong growth of new treatments before and during the season contributed to the very rapid increase in desensitization via the sublingual route (SLIT + 25%), the subcutaneous route (SCIT) decreased by 2%, remaining stable overall.
This good start of the year enables us to confirm our growth guidance for 2007.